Financial results - DRUGS4ALL SRL

Financial Summary - Drugs4All Srl
Unique identification code: 28307766
Registration number: J40/4215/2011
Nace: 4646
Sales - Ron
1.140.961
Net Profit - Ron
-164.898
Employees
Open Account
Company Drugs4All Srl with Fiscal Code 28307766 recorded a turnover of 2024 of 1.140.961, with a net profit of -164.898 and having an average number of employees of - . The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Drugs4All Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.884.891 1.681.887 1.853.122 1.465.293 1.060.004 1.422.599 6.180.609 7.055.260 2.157.153 1.140.961
Total Income - EUR 1.889.119 1.686.807 1.859.931 1.467.224 1.067.939 1.424.124 6.210.170 7.061.946 2.172.359 1.148.551
Total Expenses - EUR 1.837.027 1.655.315 1.824.466 1.516.294 1.148.258 1.470.867 6.082.471 7.242.918 2.334.264 1.313.449
Gross Profit/Loss - EUR 52.091 31.492 35.465 -49.070 -80.319 -46.743 127.700 -180.972 -161.905 -164.898
Net Profit/Loss - EUR 45.185 26.821 26.919 -49.070 -80.319 -46.743 124.899 -180.972 -161.905 -164.898
Employees 4 5 5 5 5 5 6 7 7 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -46.8%, from 2.157.153 euro in the year 2023, to 1.140.961 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Drugs4All Srl

Rating financiar

Financial Rating -
DRUGS4ALL SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Drugs4All Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Drugs4All Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Drugs4All Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Drugs4All Srl - CUI 28307766

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 10.226 5.020 6.294 45.329 43.832 34.513 27.647 66.851 63.073 38.810
Current Assets 256.881 248.987 358.701 274.660 222.931 369.870 2.664.287 7.518.523 3.345.593 2.277.213
Inventories 45.097 13.504 116.475 73.609 23.002 154.643 419.978 543.102 500.580 227.967
Receivables 164.086 202.646 212.752 171.414 168.517 179.310 2.111.974 6.913.860 2.733.198 2.014.018
Cash 47.698 32.837 29.473 29.637 31.413 35.917 132.335 61.561 111.815 35.228
Shareholders Funds 30.907 56.593 82.554 -6.303 -86.500 -143.617 -9.257 -190.258 -351.647 -647.608
Social Capital 225 223 219 215 211 207 202 203 202 201
Debts 236.200 197.415 282.482 326.332 353.263 548.046 2.701.226 7.775.935 3.761.077 2.965.289
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.277.213 euro in 2024 which includes Inventories of 227.967 euro, Receivables of 2.014.018 euro and cash availability of 35.228 euro.
The company's Equity was valued at -647.608 euro, while total Liabilities amounted to 2.965.289 euro. Equity decreased by -297.926 euro, from -351.647 euro in 2023, to -647.608 in 2024.

Risk Reports Prices

Reviews - Drugs4All Srl

Comments - Drugs4All Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.